Showing results (1711-1720 of 1,739) with videos related to

Sort By:
Pageof 174
British Journal of Haematology|May 30, 2026
Switching patients with immune thrombocytopenia (ITP) to avatrombopag from other thrombopoietin receptor agonists: The real-world experience of the Spanish ITP Group (GEPTI)Cristina Pascual-Izquierdo, José-María Bastida, David Valcárcel, et al.
Nature Communications|October 2, 2025
Cross-ancestral GWAS identifies 29 variants across head and neck cancer subsitesElmira Ebrahimi, Apiwat Sangphukieo, Hanla A Park, et al.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2013
Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulvaSilvia de Sanjosé, Laia Alemany, Jaume Ordi, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
Cross-ancestral GWAS identifies 29 novel variants across Head and Neck Cancer subsitesE Ebrahimi, A Sangphukieo, H A Park, et al.
Molecular Psychiatry|January 8, 2021
Maternal anxiety during pregnancy and newborn epigenome-wide DNA methylationSara Sammallahti, Andrea P Cortes Hidalgo, Samuli Tuominen, et al.
Journal of the National Cancer Institute|January 30, 2016
HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 PatientsXavier Castellsagué, Laia Alemany, Miquel Quer, et al.
British Journal of Haematology|March 24, 2026
Circulating levels of insulin-like growth factor I (IGF-I) and risk of multiple myeloma: An observational and Mendelian randomisation studyYolanda Benavente, Sara Hermosa, Nikos Papadimitriou, et al.
Plos One|August 22, 2022
A genome-wide association study of total child psychiatric problems scoresAlexander Neumann, Ilja M Nolte, Irene Pappa, et al.
The Lancet. Oncology|October 19, 2010
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide studySilvia de Sanjose, Wim Gv Quint, Laia Alemany, et al.
European Urology|January 9, 2021
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines PanelRichard J Sylvester, Oscar Rodríguez, Virginia Hernández, et al.
Pageof 174